首页> 外文期刊>Circulation journal >Impella 5.0 as a Bridge to Implantable Left Ventricular Assist Device ― First Clinical Case in Japan ―
【24h】

Impella 5.0 as a Bridge to Implantable Left Ventricular Assist Device ― First Clinical Case in Japan ―

机译:Impella 5.0成为植入左心室辅助装置的桥梁日本首例临床病例

获取原文
获取外文期刊封面目录资料

摘要

Short-term mechanical circulatory support has beenused to improve the hemodynamics in refractorycardiogenic shock. The Impella 5.0 (Abiomed), amicroaxial blood pump, is a minimally invasive heart assistdevice that can be used to stabilize cardiogenic shockpatients by delivering an up to 5-L/min blood flow to theaorta while directly unloading the left ventricle (LV). Wedescribe the first clinical application of the Impella 5.0 forcardiogenic shock in Japan, in which it was used as abridge to durable LV assist device (LVAD).
机译:短期机械循环支持已用于改善难治性心源性休克的血液动力学。 Impella 5.0(Abiomed)微轴血泵是一种微创心脏辅助设备,可通过在不直接向左心室(LV)卸荷的同时向主动脉输送高达5 L / min的血流量来稳定心源性休克患者。我们描述了Impella 5.0用于心源性休克的第一个临床应用,该产品被用作耐用LV辅助设备(LVAD)的缩写。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号